Emerging studies have demonstrated that IL-23 secreted by DCs and macrophages in the lesions of psoriasis patients can induce Th17 lymphocyte activation and release pro-inflammatory cytokine IL-17. The gene discussed is IL17A; the disease is psoriasis.